CLNN
Clene Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.85
−3.63%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 1.65x
- P/S forward
- 197.87x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -2.00x
- Price / sales
- 251.10x
- Price / cash flow
- -3.11x
Enterprise value
- Enterprise value
- $62.1M
- EV / sales
- 315.43x
- EV / EBITDA
- -2.23x
- EV / EBIT
- -3.06x
- Market cap
- $49.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026